Presentation EuroPCR 2013 One-Year Outcomes in 1010 Unselected Patients Treated with the PROMUS Element Everolimus-Eluting Stent: The Multicenter PROMUS Element European Post-Approval Surveillance Study Presenter: 13956|Raul Moreno May 31, 2013
Presentation EuroPCR 2013 First Report of One-Year Outcomes of the REPRISE I Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System Presenter: 203171|Ian Meredith May 31, 2013
Presentation EuroPCR 2013 Clinical, Angiographic and IVUS Outcomes of the NG PROMUS Clinical Trial Evaluating the Novel Promus PREMIER Stent Presenter: 228635|John Ormiston May 31, 2013
Presentation EuroPCR 2013 Clinical evidence in catheter-based renal sympathetic denervation - building the data Presenter: 161082|Joachim Schofer May 31, 2013
Presentation EuroPCR 2013 The Unplanned DAPT Discontinuation Patient: How Can I Make Informed Decisions? Presenter: Sigmund Silber May 22, 2013
Presentation EuroPCR 2013 Prospective, Multicenter Evaluation of the 18FDirectFlow TranscatheterAortic Valve: The DISCOVER Trial: Final Study Enrollment Presenter: Joachim Schofer May 22, 2013
Presentation EuroPCR 2013 First-in-man study of dedicated bifurcation sirolimus-eluting stent BiOSS LIM® – complete 6-month clinical results Presenter: Robert J. Gil May 22, 2013
Presentation EuroPCR 2013 First Report on the Pivotal DESolve Nx Trial: 6-month Clinical and Multimodality Imaging Results Presenter: Alexandre Abizaid May 21, 2013
Presentation EuroPCR 2012 Twelve-month clinical and angiographic results of the multicenter first-in-man BIOSOLVE-I study with the Paclitaxel-Eluting Bioabsorbable Magnesium Scaffold Presenter: 12690|Michael Haude May 18, 2012
Presentation EuroPCR 2012 Repositionable Percutaneous Replacement of a Stenotic Aortic Valve through Implantation of the Lotus Valve System Presenter: 203171|Ian Meredith May 18, 2012
Presentation EuroPCR 2012 Biolimus-Eluting Stents With Biodegradable Polymer Versus Bare Metal Stents in Acute Myocardial Infarction: the COMFORTABLE AMI Trial Presenter: 168190|Lorenz Raber May 18, 2012
Presentation EuroPCR 2012 APPOSITION III: Evaluation of the STENTYS self-apposing bare and drug-eluting stent in 1000 STEMI patients in a real-life setting: in-hospital and 30-day outcomes Presenter: 166648|giovanni amoroso May 18, 2012
Presentation EuroPCR 2012 A Randomized Comparison Between Everolimus- and Sirolimus-eluting Stent in Chronic Coronary Total Occlusions: Final Results of the CIBELES Trial Presenter: 13956|Raul Moreno May 18, 2012
Presentation EuroPCR 2012 30 Day Outcomes from the SOURCE XT TAVI Post Approval Study Presenter: 203692|Olaf Wendler May 18, 2012